Clinical Nutrition Market Report by Product (Infant Nutrition, Parental Nutrition, Enteral Nutrition), Route of Administration (Oral, Enteral, Parenteral), Application (Cancer, Malnutrition, Metabolic Disorders, Gastrointestinal Disorders, Neurological Disorders, and Others), End User (Pediatric, Adults, Geriatric), and Region 2024-2032

Clinical Nutrition Market Report by Product (Infant Nutrition, Parental Nutrition, Enteral Nutrition), Route of Administration (Oral, Enteral, Parenteral), Application (Cancer, Malnutrition, Metabolic Disorders, Gastrointestinal Disorders, Neurological Disorders, and Others), End User (Pediatric, Adults, Geriatric), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A5995
Buy Now

Clinical Nutrition Market Size:

The global clinical nutrition market size reached US$ 51.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 101.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032. The market is experiencing steady growth driven by the increasing prevalence of chronic diseases and aging populations worldwide, growing awareness about the importance of nutrition in healthcare, significant technological advancements in personalized nutrition and medical nutrition, and changing dietary patterns and lifestyle habits.

Report Attribute
 Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023 US$ 51.9 Billion
Market Forecast in 2032 US$ 101.0 Billion
Market Growth Rate 2024-2032 7.5%

Clinical Nutrition Market Analysis:

  • Market Growth and Size: The market is witnessing stable growth, driven by an aging population, rising prevalence of chronic diseases, and increasing awareness about the importance of nutrition in healthcare.
  • Technological Advancements: Technological advancements such as personalized nutrition solutions, digital health platforms, and precision medicine techniques are revolutionizing the clinical nutrition landscape. These innovations are enhancing patient outcomes, optimizing nutritional therapy, and improving overall healthcare efficiency.
  • Industry Applications: Clinical nutrition finds applications across various sectors including hospitals, long-term care facilities, home healthcare, and sports nutrition. Its role in managing chronic diseases, supporting recovery post-surgery, and optimizing athletic performance highlights its diverse applications.
  • Geographical Trends: North America and Europe dominate the clinical nutrition market due to high healthcare expenditure, advanced healthcare infrastructure, and increasing awareness about preventive healthcare measures. However, Asia-Pacific is emerging as a lucrative market owing to rapid urbanization, changing dietary habits, and improving healthcare access.
  • Competitive Landscape: The clinical nutrition market is highly competitive, with key players such as Abbott Laboratories, Nestlé Health Science, Danone, and Fresenius Kabi dominating the market. These companies focus on research and development, strategic collaborations, and product innovation to maintain their market position.
  • Challenges and Opportunities: Challenges in the clinical nutrition market include regulatory hurdles, reimbursement issues, and the high cost of specialized nutritional products. However, opportunities abound in areas, such as personalized nutrition, digital health integration, and expanding into emerging markets with unmet healthcare needs.
  • Future Outlook: The future of the clinical nutrition market looks promising, with continued growth expected due to factors, such as the increasing demand for specialized nutritional products, advancements in personalized nutrition, and expanding applications in preventive healthcare.
     

Global Clinical Nutrition Market

Clinical Nutrition Market Trends:

Aging Population and Increasing Disease Burden

The aging population is a significant driver of the clinical nutrition market. As individuals age, their nutritional needs change due to factors, such as reduced metabolism, decreased absorption of nutrients, and changes in appetite. This demographic shift is accompanied by an increased prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer, and osteoporosis, which further amplify the demand for clinical nutrition products and services. As individuals age, they often require specialized nutritional interventions to manage these chronic conditions and maintain optimal health. Clinical nutrition plays a vital role in disease management and prevention by providing tailored dietary plans, nutritional supplements, and medical foods designed to address specific nutritional deficiencies and support overall health. Moreover, the rising prevalence of obesity and related metabolic disorders adds to the demand for clinical nutrition solutions. Obesity is often associated with nutrient imbalances and metabolic dysregulation, requiring personalized dietary interventions and lifestyle modifications. Clinical nutrition programs focused on weight management, metabolic health, and nutritional counseling are essential components of comprehensive obesity management strategies.

Increasing Awareness about the Importance of Nutrition in Healthcare

There is a growing recognition of the critical role that nutrition plays in overall health and well-being, driving increased demand for clinical nutrition products and services. Healthcare professionals, policymakers, and consumers alike are increasingly acknowledging the impact of nutrition on disease prevention, treatment outcomes, and healthcare costs. Research continues to demonstrate the profound influence of diet and nutritional status on various aspects of health, from immune function and cognitive health to cardiovascular health and musculoskeletal integrity. This scientific evidence underscores the importance of incorporating nutrition into healthcare practice and public health initiatives. Healthcare providers are increasingly integrating nutrition assessment, counseling, and intervention into clinical practice to optimize patient outcomes. Nutritional screening tools, dietary assessments, and evidence-based guidelines help identify individuals at risk of malnutrition or nutrient deficiencies and guide appropriate interventions. Furthermore, consumer awareness about the link between diet and health has led to increased demand for functional foods, fortified beverages, dietary supplements, and personalized nutrition solutions. Consumers are actively seeking products that offer specific health benefits, such as immune support, digestive health, cognitive function, and sports performance.

Significant Technological Advancements in Healthcare

Advancements in medical nutrition therapy (MNT) and personalized nutrition are revolutionizing the clinical nutrition landscape, offering tailored solutions to address individual nutritional needs and health goals. MNT involves the therapeutic use of specific nutrients, dietary modifications, and nutritional supplements to prevent or manage chronic diseases and improve overall health outcomes. This evidence-based approach considers factors such as age, gender, genetics, medical history, lifestyle, and dietary preferences to develop personalized nutrition plans tailored to the unique needs of each individual. Recent advancements in technology, such as nutrigenomics and metabolomics, have enabled a deeper understanding of how genetic variations and metabolic pathways influence nutrient metabolism, response to dietary interventions, and susceptibility to chronic diseases. This knowledge allows healthcare providers to offer targeted nutritional recommendations based on genetic predispositions and metabolic profiles, optimizing the effectiveness of dietary interventions and improving patient outcomes. Additionally, digital health platforms, wearable devices, and mobile apps facilitate remote monitoring, real-time feedback, and personalized coaching, enhancing patient engagement and adherence to dietary interventions. These technological innovations empower individuals to take an active role in managing their health through personalized nutrition and lifestyle modifications.

Changing Dietary Patterns and Nutritional Needs

Changing dietary patterns, lifestyle habits, and socioeconomic factors are influencing nutritional needs and driving demand for clinical nutrition products and services. Urbanization, globalization, and economic development have led to shifts in dietary habits, with increased consumption of processed foods, convenience foods, and fast-food diets high in refined sugars, unhealthy fats, and sodium. These dietary patterns contribute to the rising prevalence of obesity, diabetes, cardiovascular disease, and other diet-related chronic conditions, necessitating interventions to promote healthier eating habits and improve nutritional status. Furthermore, changing lifestyles, such as sedentary behavior, irregular meal patterns, and high-stress levels, impact nutrient requirements and metabolism, increasing the risk of malnutrition, micronutrient deficiencies, and metabolic disorders. Inadequate intake of essential nutrients, coupled with excessive calorie consumption and nutrient-poor food choices, contributes to nutritional imbalances and poor health outcomes. Moreover, demographic factors such as population growth, urbanization, aging populations, and cultural diversity influence dietary preferences, nutritional needs, and health disparities across different regions and population groups. Ethnic and cultural dietary traditions, religious beliefs, food availability, and socioeconomic status shape dietary patterns and nutritional behaviors, highlighting the importance of culturally sensitive and context-specific nutrition interventions.

Clinical Nutrition Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, route of administration, application and end user.

Breakup by Product:

  • Infant Nutrition
  • Parental Nutrition
  • Enteral Nutrition
     

Infant nutrition accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes infant nutrition, parental nutrition, and enteral nutrition. According to the report, infant nutrition represented the largest segment.

Infant nutrition represents a crucial segment within the clinical nutrition market, catering to the nutritional needs of newborns and infants during their early developmental stages. Breast milk is considered the gold standard for infant nutrition due to its unique composition of essential nutrients, bioactive compounds, and antibodies that support optimal growth, development, and immune function. However, in cases where breastfeeding is not possible or insufficient, infant formula serves as a viable alternative, providing essential nutrients such as proteins, carbohydrates, fats, vitamins, and minerals necessary for healthy growth and development. Specialized infant formulas are available to meet the specific needs of premature infants, infants with allergies or intolerances, and those with medical conditions requiring nutritional supplementation or modification.

Parental nutrition plays a vital role in providing essential nutrients, fluids, and electrolytes to individuals who cannot adequately absorb nutrients through the gastrointestinal tract due to conditions such as gastrointestinal disorders, malabsorption syndromes, or surgical interventions. Parenteral nutrition formulations are administered intravenously and are composed of a balanced mixture of carbohydrates, proteins, lipids, vitamins, minerals, and trace elements tailored to meet the specific nutritional requirements of the patient. These specialized formulations bypass the digestive system, delivering nutrients directly into the bloodstream to support cellular function, tissue repair, and metabolic processes.

Enteral nutrition refers to the delivery of nutrients directly into the gastrointestinal tract via a feeding tube, bypassing the oral cavity and esophagus, and providing nutrition to individuals who are unable to eat or swallow adequately due to conditions such as dysphagia, neurological disorders, or mechanical obstruction. Enteral nutrition formulations are available in various forms, including liquid formulas, powders, and modular components, tailored to meet the nutritional needs of the patient, digestive capabilities, and medical conditions. These formulations provide essential nutrients such as proteins, carbohydrates, fats, vitamins, and minerals in a well-balanced and easily digestible format, supporting nutritional repletion, maintenance, or supplementation.

Breakup by Route of Administration:

  • Oral
  • Enteral
  • Parenteral
     

Oral holds the largest share in the industry

A detailed breakup and analysis of the market based on the route of administration have also been provided in the report. This includes oral, enteral, and parenteral. According to the report, oral accounted for the largest market share.

The oral route of administration dominates the clinical nutrition market, accounting for the largest share of revenue. This segment encompasses a wide range of oral nutritional products, including oral nutritional supplements (ONS), functional foods, dietary supplements, and over-the-counter (OTC) medications. Oral nutrition products are available in various forms such as liquids, powders, capsules, tablets, and bars, offering convenient and accessible options for individuals with diverse nutritional needs. These products are typically consumed orally and absorbed through the gastrointestinal tract, providing essential nutrients, vitamins, minerals, and macronutrients to support overall health, meet dietary requirements, and address specific nutritional deficiencies.

The enteral route of administration involves the delivery of nutritional support directly into the gastrointestinal tract via a feeding tube. Enteral nutrition is commonly used in patients who are unable to consume adequate oral nutrition due to medical conditions such as dysphagia, malabsorption disorders, gastrointestinal surgery, or critical illness. Enteral nutrition products include enteral formulae, tube feeding solutions, and enteral feeding pumps, which deliver a balanced mix of macronutrients, micronutrients, vitamins, and minerals to meet the nutritional requirements of patients.

The parenteral route of administration involves the delivery of nutrients directly into the bloodstream via intravenous infusion, bypassing the gastrointestinal tract. Parenteral nutrition is indicated in patients who are unable to tolerate enteral nutrition or have severe malabsorption, intestinal failure, or gastrointestinal obstruction. Parenteral nutrition solutions contain a balanced mix of carbohydrates, proteins, fats, electrolytes, vitamins, and trace elements, providing essential nutrients to meet metabolic requirements and prevent malnutrition. Parenteral nutrition is typically administered through central venous catheters (CVCs) or peripherally inserted central catheters (PICCs) under sterile conditions to minimize the risk of infection and complications.

Breakup by Application:

  • Cancer
  • Malnutrition
  • Metabolic Disorders
  • Gastrointestinal Disorders
  • Neurological Disorders
  • Others
     

The report has provided a detailed breakup and analysis of the market based on the application. This includes cancer, malnutrition, metabolic disorders, gastrointestinal disorders, neurological disorders, and others.

The clinical nutrition market for cancer patients addresses the unique nutritional challenges associated with the disease and its treatment. Cancer and its treatments such as chemotherapy, radiation therapy, and surgery can significantly impact the nutritional status of a pateint by causing appetite loss, nausea, vomiting, taste alterations, and metabolic changes. Malnutrition is prevalent among cancer patients, leading to compromised immune function, impaired wound healing, muscle wasting, and decreased quality of life. Clinical nutrition interventions for cancer patients focus on providing adequate energy, protein, vitamins, minerals, and fluids to support nutritional status, preserve lean body mass, and enhance treatment tolerance and effectiveness.

Malnutrition is a significant concern in healthcare settings and encompasses various conditions characterized by inadequate intake or absorption of nutrients, leading to nutrient deficiencies, weight loss, muscle wasting, and impaired immune function. Malnutrition can result from underlying medical conditions such as gastrointestinal disorders, chronic diseases, infections, trauma, or surgical procedures, as well as factors, such as aging, social isolation, and economic insecurity. Clinical nutrition interventions for malnutrition aim to address nutrient deficiencies, restore energy balance, promote weight gain, and improve overall nutritional status.

Metabolic disorders encompass a diverse group of conditions characterized by abnormalities in energy metabolism, hormone regulation, nutrient utilization, or enzyme function, leading to metabolic imbalances and health complications. Instances of metabolic disorders include diabetes mellitus, obesity, dyslipidemia, metabolic syndrome, and inborn errors of metabolism. Clinical nutrition plays a pivotal role in managing metabolic disorders by optimizing dietary patterns, controlling blood glucose levels, managing body weight, and reducing cardiovascular risk factors. Nutrition therapy for metabolic disorders emphasizes balanced macronutrient intake, portion control, carbohydrate counting, glycemic index management, and dietary fiber consumption to achieve glycemic control, weight management, and cardiovascular health.

Gastrointestinal disorders encompass a wide range of conditions affecting the digestive tract, including the esophagus, stomach, intestines, liver, gallbladder, and pancreas. Instances of gastrointestinal disorders include gastroesophageal reflux disease (GERD), peptic ulcers, inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, liver cirrhosis, and pancreatitis. These conditions can impair nutrient digestion, absorption, and metabolism, leading to malnutrition, nutrient deficiencies, weight loss, and gastrointestinal symptoms such as abdominal pain, bloating, diarrhea, or constipation. Clinical nutrition interventions for gastrointestinal disorders focus on optimizing nutrient intake, alleviating symptoms, managing complications, and supporting gastrointestinal health.

Neurological disorders affect the central nervous system, peripheral nervous system, or neuromuscular system and can result in cognitive impairment, motor dysfunction, sensory disturbances, and autonomic dysfunction. Instances of neurological disorders include Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, stroke, traumatic brain injury, and neuropathies. These conditions may impact nutritional status and dietary intake through various mechanisms such as dysphagia, swallowing difficulties, impaired mobility, cognitive impairment, medication side effects, or autonomic dysfunction. Clinical nutrition interventions for neurological disorders aim to address nutritional deficiencies, promote brain health, optimize functional status, and manage symptoms related to feeding, swallowing, and gastrointestinal function.

Breakup by End User:

  • Pediatric
  • Adults
  • Geriatric
     

Pediatric exhibits a clear dominance in the market 

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes pediatric, adults, and geriatric. According to the report, pediatric accounted for the largest market share.

The pediatric segment of the clinical nutrition market encompasses infants, children, and adolescents, representing a critical demographic with unique nutritional needs and health considerations. In this segment, clinical nutrition plays a pivotal role in supporting growth, development, and overall health during critical stages of life. For infants, breastfeeding and formula feeding provide essential nutrients crucial for optimal growth and development, while specialized infant formulas cater to specific dietary requirements for infants with allergies, intolerances, or medical conditions. As children transition to solid foods and develop their eating habits, pediatric clinical nutrition focuses on promoting balanced diets, addressing nutrient deficiencies, and preventing childhood obesity and related health problems.

The adult segment of the clinical nutrition market encompasses individuals ranging from young adults to middle-aged and older adults, representing a diverse population with varied nutritional needs and health concerns. In this segment, clinical nutrition plays a crucial role in promoting health maintenance, disease prevention, and optimal functioning across the lifespan. For young adults, clinical nutrition focuses on supporting healthy lifestyles, managing weight, and preventing chronic diseases through balanced diets, regular physical activity, and lifestyle modifications. As individuals age, nutritional needs may change due to factors such as decreased metabolism, changes in body composition, and increased risk of chronic conditions such as cardiovascular disease, diabetes, and osteoporosis.

The geriatric segment of the clinical nutrition market focuses on the nutritional needs and health challenges of older adults, typically aged 65 years and above, representing a rapidly growing demographic with unique nutritional requirements and age-related health conditions. In this segment, clinical nutrition plays a critical role in addressing age-related changes in metabolism, digestive function, nutrient absorption, and overall health status. Older adults often experience decreased appetite, taste changes, chewing difficulties, and reduced mobility, which can lead to inadequate nutrient intake, malnutrition, and functional decline. Clinical nutrition interventions for the geriatric population aim to prevent malnutrition, maintain muscle mass and strength, support bone health, enhance cognitive function, and improve immune function, thus promoting healthy aging and preserving independence.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Asia Pacific leads the market, accounting for the largest clinical nutrition market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific accounted for the largest market share.

The Asia Pacific region represents a lucrative market for clinical nutrition, driven by rapid urbanization, changing dietary habits, and a rising burden of chronic diseases. Economic development, increasing disposable income, and expanding healthcare access contribute to growing demand for clinical nutrition products and services in Asia Pacific. The region is characterized by a diverse population, varying nutritional needs, and cultural preferences, creating opportunities for customized nutritional solutions tailored to specific demographics and healthcare needs. Key players such as Abbott Laboratories, Nestlé Health Science, and Fresenius Kabi are expanding their presence in the Asia Pacific market through strategic partnerships, product localization, and targeted marketing initiatives.

North America dominates the clinical nutrition market owing to factors such as high healthcare expenditure, advanced healthcare infrastructure, and increasing prevalence of chronic diseases. The region is characterized by a strong focus on preventive healthcare and wellness initiatives, driving demand for clinical nutrition products and services aimed at managing chronic conditions, supporting healthy aging, and optimizing overall health outcomes. Technological advancements, such as personalized nutrition solutions and digital health platforms, are widely adopted in North America, facilitating remote monitoring, real-time data analysis, and personalized interventions.

Europe is a significant market for clinical nutrition, characterized by a growing elderly population, increasing healthcare expenditure, and a strong emphasis on preventive healthcare and nutritional interventions. The region has well-established healthcare systems, robust research infrastructure, and supportive regulatory frameworks, fostering innovation and adoption of advanced nutritional therapies. Increasing awareness about the importance of nutrition in managing chronic diseases, coupled with rising demand for personalized nutrition solutions, drives market growth in Europe. Key players such as Nestlé Health Science, Abbott Laboratories, and Danone dominate the European market, offering a wide range of clinical nutrition products and services tailored to diverse healthcare needs. Geographical variations in dietary habits, cultural preferences, and disease epidemiology influence market dynamics across European countries, necessitating localized strategies and product offerings to address unique market requirements.

Latin America is an emerging market for clinical nutrition, characterized by a growing population, increasing urbanization, and rising healthcare expenditure. The region faces significant health challenges, including high rates of malnutrition, micronutrient deficiencies, and a rising burden of chronic diseases such as obesity, diabetes, and cardiovascular disease. Clinical nutrition interventions play a crucial role in addressing these health issues, providing targeted nutritional support, dietary counseling, and medical foods to improve health outcomes. Key players in the Latin American market include Abbott Laboratories, Nestlé Health Science, and Danone, which are investing in expanding their product portfolios and distribution networks to capitalize on growing demand for clinical nutrition products and services.

The Middle East and Africa represent a diverse market for clinical nutrition, characterized by varying levels of economic development, healthcare infrastructure, and disease epidemiology across different countries and regions. The region faces unique health challenges, including malnutrition, micronutrient deficiencies, and a high prevalence of chronic diseases such as diabetes, cardiovascular disease, and obesity. Clinical nutrition interventions are increasingly recognized as essential components of healthcare management in the Middle East and Africa, providing nutritional support, dietary counseling, and medical foods to address these health issues. Key players such as Abbott Laboratories, Nestlé Health Science, and Danone are expanding their presence in the Middle East and Africa through strategic partnerships, product localization, and targeted marketing initiatives.

Leading Key Players in the Clinical Nutrition Industry:

Key players in the clinical nutrition market, such as Abbott Laboratories, Nestlé Health Science, and Danone, are actively engaged in strategic initiatives to maintain and expand their market share. These companies are focusing on research and development to innovate new products and formulations that address evolving healthcare needs, such as personalized nutrition solutions and functional foods targeting specific health conditions. Additionally, they are leveraging strategic partnerships, acquisitions, and collaborations to enhance their product portfolios, expand their geographic presence, and access new markets. Marketing efforts emphasize the efficacy, safety, and value proposition of their products, aiming to differentiate their offerings and capture consumer mindshare.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BASF SE
  • Baxter International Inc.
  • Danone S.A.
  • Fresenius SE & Co. KGaA
  • Grifols S.A.
  • Koninklijke DSM N.V.
  • Meiji Holdings Co. Ltd.
  • Nestlé S.A.
  • Perrigo Company plc
  • Reckitt Benckiser Group PLC.
     

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

  • April, 2021: In a collaborative effort, BASF and NutiFood have joined forces to develop products enriched with human milk oligosaccharides (HMO). NutiFood, being the first dairy company in Vietnam, has embarked on a partnership with a European counterpart to integrate HMO into its range of nutritional products. These goods are designed to be consumed orally, offering a convenient method of intake. This collaboration underscores the commitment to innovation in the medical nutrition sector and also extends the scope for growth and advancement within the industry.
  • April, 2022: Baxter International Inc., a prominent provider of patient monitoring, physical assessment, and vision screening solutions, has revealed the results of an observational study utilizing data from the Starling Registry. This research, sponsored by Baxter, suggests that tracking trends in stroke volume and cardiac output among patients with critical conditions could offer valuable insights into cardiac performance and potentially aid in forecasting patient outcomes, including mortality.
  • May, 2022: Abbott disclosed that the United States District Court for the Western District of Michigan had revised the recent consent decree, permitting Abbott to distribute restricted quantities of its EleCare specialty amino acid-based formulas. These products were previously halted following the recall of certain powdered infant formulas from its Sturgis, Mich., facility on February 17th. Abbott, in collaboration with the US Food and Drug Administration (FDA), sought the modification of the consent decree to enable the provision of EleCare to children in critical medical situations. Pursuant to an agreement with the FDA, specific batches of EleCare products were placed on hold.

Clinical Nutrition Market Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
  • Product
  • Route of Administration
  • Application
  • End User
  • Region
Products Covered Infant Nutrition, Parental Nutrition, Enteral Nutrition
Route of Administrations Covered Oral, Enteral, Parenteral
Applications Covered Cancer, Malnutrition, Metabolic Disorders, Gastrointestinal Disorders, Neurological Disorders, Others
End Users Covered Pediatric, Adults, Geriatric
Regions Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, B. Braun Melsungen AG, BASF SE, Baxter International Inc., Danone S.A., Fresenius SE & Co. KGaA, Grifols S.A., Koninklijke DSM N.V., Meiji Holdings Co. Ltd., Nestlé S.A., Perrigo Company plc, Reckitt Benckiser Group PLC, etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the clinical nutrition market from 2018-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the global clinical nutrition market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the clinical nutrition industry and its attractiveness.
  • The competitive landscape allows stakeholders to understand their competitive environment and provides insight into the current positions of key players in the market.

Key Questions Answered in This Report

The global clinical nutrition market was valued at US$ 51.9 Billion in 2023.

We expect the global clinical nutrition market to exhibit a CAGR of 7.5% during 2024-2032.

The rising popularity of clinical nutrition, as it assists in reducing the consequences of malnutrition, enhancing the response to disease treatment, boosting immunity levels, etc., is primarily driving the global clinical nutrition market.

The sudden outbreak of the COVID-19 pandemic has led to the increasing demand for immunity-boosting alternatives, including clinical nutrition, to prevent the risk of the coronavirus infection.

Based on the product, the global clinical nutrition market can be categorized into infant nutrition, parental nutrition, and enteral nutrition. Currently, infant nutrition holds the majority of the total market share.

Based on the route of administration, the global clinical nutrition market has been segregated into oral, enteral, and parenteral. Among these, oral currently exhibits a clear dominance in the market. 

Based on the end user, the global clinical nutrition market can be bifurcated into pediatric, adults, and geriatric. Currently, pediatric accounts for the largest market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where Asia-Pacific currently dominates the global market.

Some of the major players in the global clinical nutrition market include Abbott Laboratories, B. Braun Melsungen AG, BASF SE, Baxter International Inc., Danone S.A., Fresenius SE & Co. KGaA, Grifols S.A., Koninklijke DSM N.V., Meiji Holdings Co. Ltd., Nestlé S.A., Perrigo Company plc, and Reckitt Benckiser Group PLC.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Clinical Nutrition Market Report by Product (Infant Nutrition, Parental Nutrition, Enteral Nutrition), Route of Administration (Oral, Enteral, Parenteral), Application (Cancer, Malnutrition, Metabolic Disorders, Gastrointestinal Disorders, Neurological Disorders, and Others), End User (Pediatric, Adults, Geriatric), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More